We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Open Tube Hematology Analyzer Is Compact and Versatile

By LabMedica International staff writers
Posted on 05 Nov 2009
Print article
An open tube analyzer enables flexible and convenient in vitro diagnostic (IVD) testing of whole blood specimens.

The compact hematology analyzer is ideal for situations where there are various types of sample tubes and sample types. Called Pentra ES60, it covers 26 parameters including complete blood cell (CBC) and differential (DIFF) counts. It also counts atypical lymphocytes and large immature cells and processes up to 60 samples an hour.

The Pentra ES 60's integrated multi-distribution sampling system (MDSS) enables micro-sampling (30 µL in CBC mode and 53 µL in CBC + DIFF), making the analyzer ideal for pediatric or geriatric sample types, where only small sample volumes are available.

Ideal as a standalone analyzer for small to medium sized laboratories, the Pentra ES 60 is a compact bench top system, designed to take up minimal workspace. The analyzer's Windows-based software makes it simple to use. It is adaptable to enable threshold adjustments for specific sample types. The simplicity of the analyzer's design also means there is no daily maintenance, just one automatic start up and shut down each day.

Launched by Horiba Medical (Moulton Park, UK) the Pentra ES 60 five-part differential (Diff) analyzer expands the company's open tube hematology analysis range. To ensure system security, the Pentra ES 60 can be set up with password-protected access, which also enables full audit trails for quality assurance purposes.

Horiba Medical designs and manufactures automated in vitro diagnostic systems for hematology as well as chemistry focused analytical solutions. From compact point-of-care (POC) to high throughput systems, Horiba Medical has developed an array of analyzers and data management solutions to meet many needs, enabling analysis wherever it is required.

Related Links:
Horiba Medical

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Bordetella Pertussis Molecular Assay
Alethia Pertussis
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Sekisui Diagnostics UK Ltd.